Proteome Sciences plc Appoint Richard Dennis as Chief Commercial Officer

Proteome Sciences Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Proteome Sciences plc (LON:PRM) has today confirmed that Richard Dennis has joined us as Chief Commercial Officer, the first person to hold such a role at Proteome Sciences. Richard brings over 30 years’ experience of strategic sales and marketing, combined with significant technical knowledge, gained most recently as Director of International Commercial Operations at Quanterix Corp. where he was instrumental in establishing successful sales organisations in Europe, Japan and China. Previously he had held positions of increasing commercial responsibility at Bioscale Inc. and Meso Scale Discovery.

Richard Dennis commented: “I have been involved with proteins throughout my commercial career and am excited to be joining Proteome Sciences at this time. Never has the ‘power of the protein’ been better understood by, and more important to, the scientific community. Proteome Sciences can fully exploit this potential and I look forward to leading the commercial team to achieve this.”

Jeremy Haigh, Proteome Sciences plc Chief Executive Officer, commented: “Given the critical importance of commercialising our biomarker services to the future success of Proteome Sciences, I am delighted to welcome Richard Dennis to the Company as our first Chief Commercial Officer. His experience of building successful sales organisations across the world makes him a hugely valuable addition to the Company and I look forward to working with him as he executes a commercial plan for the services business and provides integrated commercial leadership for the Company.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search